nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftriaxone—ALB—breast cancer	0.265	1	CbGaD
Ceftriaxone—SLC22A11—Methotrexate—breast cancer	0.0488	0.277	CbGbCtD
Ceftriaxone—ALB—Irinotecan—breast cancer	0.0318	0.181	CbGbCtD
Ceftriaxone—ALB—Fluorouracil—breast cancer	0.0305	0.173	CbGbCtD
Ceftriaxone—SLC22A8—Methotrexate—breast cancer	0.0284	0.161	CbGbCtD
Ceftriaxone—SLC22A6—Methotrexate—breast cancer	0.0198	0.112	CbGbCtD
Ceftriaxone—ALB—Methotrexate—breast cancer	0.0168	0.0956	CbGbCtD
Ceftriaxone—GLUL—mammary gland—breast cancer	0.00465	0.0853	CbGeAlD
Ceftriaxone—GLUL—embryo—breast cancer	0.00318	0.0582	CbGeAlD
Ceftriaxone—ALB—mammary gland—breast cancer	0.00288	0.0528	CbGeAlD
Ceftriaxone—GLUL—epithelium—breast cancer	0.00259	0.0475	CbGeAlD
Ceftriaxone—GLUL—skin of body—breast cancer	0.00247	0.0452	CbGeAlD
Ceftriaxone—SLC15A2—mammary gland—breast cancer	0.00241	0.0441	CbGeAlD
Ceftriaxone—GLUL—endometrium—breast cancer	0.00232	0.0426	CbGeAlD
Ceftriaxone—SLC15A1—epithelium—breast cancer	0.00214	0.0393	CbGeAlD
Ceftriaxone—GLUL—uterus—breast cancer	0.00214	0.0392	CbGeAlD
Ceftriaxone—GLUL—pituitary gland—breast cancer	0.0021	0.0385	CbGeAlD
Ceftriaxone—GLUL—adipose tissue—breast cancer	0.0021	0.0384	CbGeAlD
Ceftriaxone—SLC22A11—female reproductive system—breast cancer	0.00203	0.0372	CbGeAlD
Ceftriaxone—GLUL—female reproductive system—breast cancer	0.00193	0.0353	CbGeAlD
Ceftriaxone—SLC15A1—endometrium—breast cancer	0.00192	0.0352	CbGeAlD
Ceftriaxone—GLUL—adrenal gland—breast cancer	0.00188	0.0344	CbGeAlD
Ceftriaxone—GLUL—bone marrow—breast cancer	0.00182	0.0333	CbGeAlD
Ceftriaxone—GLUL—female gonad—breast cancer	0.00175	0.0321	CbGeAlD
Ceftriaxone—SLC22A11—endocrine gland—breast cancer	0.00172	0.0315	CbGeAlD
Ceftriaxone—GLUL—endocrine gland—breast cancer	0.00163	0.0299	CbGeAlD
Ceftriaxone—SLC15A1—endocrine gland—breast cancer	0.00135	0.0247	CbGeAlD
Ceftriaxone—SLC15A2—endometrium—breast cancer	0.0012	0.022	CbGeAlD
Ceftriaxone—ALB—adrenal gland—breast cancer	0.00116	0.0213	CbGeAlD
Ceftriaxone—GLUL—lymph node—breast cancer	0.00113	0.0206	CbGeAlD
Ceftriaxone—SLC15A2—pituitary gland—breast cancer	0.00109	0.0199	CbGeAlD
Ceftriaxone—SLC15A2—female reproductive system—breast cancer	0.000995	0.0182	CbGeAlD
Ceftriaxone—SLC15A2—adrenal gland—breast cancer	0.000971	0.0178	CbGeAlD
Ceftriaxone—SLC15A2—female gonad—breast cancer	0.000906	0.0166	CbGeAlD
Ceftriaxone—SLC15A2—endocrine gland—breast cancer	0.000842	0.0154	CbGeAlD
Ceftriaxone—ALB—lymph node—breast cancer	0.000698	0.0128	CbGeAlD
Ceftriaxone—SLC15A2—lymph node—breast cancer	0.000582	0.0107	CbGeAlD
Ceftriaxone—Cefotetan—ALB—breast cancer	0.00027	0.267	CrCbGaD
Ceftriaxone—Cefpiramide—ALB—breast cancer	0.000235	0.232	CrCbGaD
Ceftriaxone—Cefonicid—ALB—breast cancer	0.000205	0.202	CrCbGaD
Ceftriaxone—Body temperature increased—Mitoxantrone—breast cancer	0.00016	0.000427	CcSEcCtD
Ceftriaxone—Abdominal pain—Irinotecan—breast cancer	0.00016	0.000427	CcSEcCtD
Ceftriaxone—Body temperature increased—Irinotecan—breast cancer	0.00016	0.000427	CcSEcCtD
Ceftriaxone—Aspartate aminotransferase increased—Doxorubicin—breast cancer	0.00016	0.000426	CcSEcCtD
Ceftriaxone—Toxic epidermal necrolysis—Doxorubicin—breast cancer	0.00016	0.000426	CcSEcCtD
Ceftriaxone—Feeling abnormal—Fluorouracil—breast cancer	0.000159	0.000426	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Paclitaxel—breast cancer	0.000159	0.000425	CcSEcCtD
Ceftriaxone—Anaemia—Docetaxel—breast cancer	0.000158	0.000422	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Methotrexate—breast cancer	0.000157	0.000418	CcSEcCtD
Ceftriaxone—Vomiting—Vinorelbine—breast cancer	0.000156	0.000416	CcSEcCtD
Ceftriaxone—Body temperature increased—Gemcitabine—breast cancer	0.000156	0.000415	CcSEcCtD
Ceftriaxone—Renal failure—Methotrexate—breast cancer	0.000155	0.000414	CcSEcCtD
Ceftriaxone—Neutropenia—Epirubicin—breast cancer	0.000155	0.000414	CcSEcCtD
Ceftriaxone—Dizziness—Thiotepa—breast cancer	0.000155	0.000413	CcSEcCtD
Ceftriaxone—Rash—Vinorelbine—breast cancer	0.000154	0.000412	CcSEcCtD
Ceftriaxone—Dermatitis—Vinorelbine—breast cancer	0.000154	0.000412	CcSEcCtD
Ceftriaxone—Stomatitis—Methotrexate—breast cancer	0.000154	0.000411	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Capecitabine—breast cancer	0.000154	0.000411	CcSEcCtD
Ceftriaxone—Urticaria—Fluorouracil—breast cancer	0.000154	0.000411	CcSEcCtD
Ceftriaxone—Headache—Vinorelbine—breast cancer	0.000153	0.00041	CcSEcCtD
Ceftriaxone—Leukopenia—Docetaxel—breast cancer	0.000153	0.000409	CcSEcCtD
Ceftriaxone—Anaemia—Capecitabine—breast cancer	0.000153	0.000409	CcSEcCtD
Ceftriaxone—Body temperature increased—Fluorouracil—breast cancer	0.000153	0.000408	CcSEcCtD
Ceftriaxone—Eosinophilia—Doxorubicin—breast cancer	0.000152	0.000405	CcSEcCtD
Ceftriaxone—Palpitations—Docetaxel—breast cancer	0.000151	0.000404	CcSEcCtD
Ceftriaxone—Haematuria—Methotrexate—breast cancer	0.000151	0.000402	CcSEcCtD
Ceftriaxone—Pancreatitis—Doxorubicin—breast cancer	0.00015	0.000401	CcSEcCtD
Ceftriaxone—Malaise—Capecitabine—breast cancer	0.000149	0.000399	CcSEcCtD
Ceftriaxone—Epistaxis—Methotrexate—breast cancer	0.000149	0.000398	CcSEcCtD
Ceftriaxone—Hypersensitivity—Irinotecan—breast cancer	0.000149	0.000398	CcSEcCtD
Ceftriaxone—Hypersensitivity—Mitoxantrone—breast cancer	0.000149	0.000398	CcSEcCtD
Ceftriaxone—Vomiting—Thiotepa—breast cancer	0.000149	0.000397	CcSEcCtD
Ceftriaxone—Leukopenia—Capecitabine—breast cancer	0.000148	0.000396	CcSEcCtD
Ceftriaxone—Convulsion—Docetaxel—breast cancer	0.000148	0.000396	CcSEcCtD
Ceftriaxone—Paraesthesia—Paclitaxel—breast cancer	0.000148	0.000395	CcSEcCtD
Ceftriaxone—Rash—Thiotepa—breast cancer	0.000148	0.000394	CcSEcCtD
Ceftriaxone—Dermatitis—Thiotepa—breast cancer	0.000147	0.000394	CcSEcCtD
Ceftriaxone—Agranulocytosis—Methotrexate—breast cancer	0.000147	0.000393	CcSEcCtD
Ceftriaxone—Headache—Thiotepa—breast cancer	0.000147	0.000391	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Epirubicin—breast cancer	0.000146	0.000391	CcSEcCtD
Ceftriaxone—Palpitations—Capecitabine—breast cancer	0.000146	0.000391	CcSEcCtD
Ceftriaxone—Nausea—Vinorelbine—breast cancer	0.000146	0.000389	CcSEcCtD
Ceftriaxone—Renal failure—Epirubicin—breast cancer	0.000145	0.000388	CcSEcCtD
Ceftriaxone—Dyspepsia—Paclitaxel—breast cancer	0.000145	0.000387	CcSEcCtD
Ceftriaxone—Jaundice—Epirubicin—breast cancer	0.000144	0.000384	CcSEcCtD
Ceftriaxone—Stomatitis—Epirubicin—breast cancer	0.000144	0.000384	CcSEcCtD
Ceftriaxone—Neutropenia—Doxorubicin—breast cancer	0.000143	0.000383	CcSEcCtD
Ceftriaxone—Hypersensitivity—Fluorouracil—breast cancer	0.000143	0.000381	CcSEcCtD
Ceftriaxone—Haemoglobin—Methotrexate—breast cancer	0.000142	0.00038	CcSEcCtD
Ceftriaxone—Haemorrhage—Methotrexate—breast cancer	0.000142	0.000378	CcSEcCtD
Ceftriaxone—Pain—Paclitaxel—breast cancer	0.000141	0.000376	CcSEcCtD
Ceftriaxone—Haematuria—Epirubicin—breast cancer	0.000141	0.000376	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Docetaxel—breast cancer	0.00014	0.000373	CcSEcCtD
Ceftriaxone—Oedema—Docetaxel—breast cancer	0.00014	0.000373	CcSEcCtD
Ceftriaxone—Discomfort—Capecitabine—breast cancer	0.000139	0.000372	CcSEcCtD
Ceftriaxone—Epistaxis—Epirubicin—breast cancer	0.000139	0.000372	CcSEcCtD
Ceftriaxone—Pruritus—Gemcitabine—breast cancer	0.000139	0.000372	CcSEcCtD
Ceftriaxone—Nausea—Thiotepa—breast cancer	0.000139	0.000371	CcSEcCtD
Ceftriaxone—Infection—Docetaxel—breast cancer	0.000139	0.000371	CcSEcCtD
Ceftriaxone—Diarrhoea—Mitoxantrone—breast cancer	0.000138	0.000369	CcSEcCtD
Ceftriaxone—Diarrhoea—Irinotecan—breast cancer	0.000138	0.000369	CcSEcCtD
Ceftriaxone—Agranulocytosis—Epirubicin—breast cancer	0.000138	0.000368	CcSEcCtD
Ceftriaxone—Pruritus—Fluorouracil—breast cancer	0.000137	0.000366	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Docetaxel—breast cancer	0.000137	0.000365	CcSEcCtD
Ceftriaxone—Feeling abnormal—Paclitaxel—breast cancer	0.000136	0.000363	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Doxorubicin—breast cancer	0.000136	0.000362	CcSEcCtD
Ceftriaxone—Oedema—Capecitabine—breast cancer	0.000135	0.000361	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Paclitaxel—breast cancer	0.000135	0.00036	CcSEcCtD
Ceftriaxone—Diarrhoea—Gemcitabine—breast cancer	0.000135	0.00036	CcSEcCtD
Ceftriaxone—Renal failure—Doxorubicin—breast cancer	0.000134	0.000359	CcSEcCtD
Ceftriaxone—Infection—Capecitabine—breast cancer	0.000134	0.000359	CcSEcCtD
Ceftriaxone—Erythema multiforme—Methotrexate—breast cancer	0.000134	0.000358	CcSEcCtD
Ceftriaxone—Dizziness—Irinotecan—breast cancer	0.000134	0.000357	CcSEcCtD
Ceftriaxone—Haemoglobin—Epirubicin—breast cancer	0.000133	0.000356	CcSEcCtD
Ceftriaxone—Jaundice—Doxorubicin—breast cancer	0.000133	0.000356	CcSEcCtD
Ceftriaxone—Stomatitis—Doxorubicin—breast cancer	0.000133	0.000356	CcSEcCtD
Ceftriaxone—Haemorrhage—Epirubicin—breast cancer	0.000133	0.000354	CcSEcCtD
Ceftriaxone—Diarrhoea—Fluorouracil—breast cancer	0.000132	0.000354	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Capecitabine—breast cancer	0.000132	0.000354	CcSEcCtD
Ceftriaxone—Urticaria—Paclitaxel—breast cancer	0.000131	0.00035	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Capecitabine—breast cancer	0.000131	0.000349	CcSEcCtD
Ceftriaxone—Haematuria—Doxorubicin—breast cancer	0.00013	0.000348	CcSEcCtD
Ceftriaxone—Abdominal pain—Paclitaxel—breast cancer	0.00013	0.000348	CcSEcCtD
Ceftriaxone—Body temperature increased—Paclitaxel—breast cancer	0.00013	0.000348	CcSEcCtD
Ceftriaxone—Epistaxis—Doxorubicin—breast cancer	0.000129	0.000344	CcSEcCtD
Ceftriaxone—Vomiting—Irinotecan—breast cancer	0.000128	0.000343	CcSEcCtD
Ceftriaxone—Vomiting—Mitoxantrone—breast cancer	0.000128	0.000343	CcSEcCtD
Ceftriaxone—Dizziness—Fluorouracil—breast cancer	0.000128	0.000342	CcSEcCtD
Ceftriaxone—Agranulocytosis—Doxorubicin—breast cancer	0.000128	0.000341	CcSEcCtD
Ceftriaxone—Rash—Mitoxantrone—breast cancer	0.000127	0.00034	CcSEcCtD
Ceftriaxone—Rash—Irinotecan—breast cancer	0.000127	0.00034	CcSEcCtD
Ceftriaxone—Dermatitis—Irinotecan—breast cancer	0.000127	0.00034	CcSEcCtD
Ceftriaxone—Dermatitis—Mitoxantrone—breast cancer	0.000127	0.00034	CcSEcCtD
Ceftriaxone—Chills—Methotrexate—breast cancer	0.000127	0.000339	CcSEcCtD
Ceftriaxone—Headache—Mitoxantrone—breast cancer	0.000127	0.000338	CcSEcCtD
Ceftriaxone—Headache—Irinotecan—breast cancer	0.000127	0.000338	CcSEcCtD
Ceftriaxone—Paraesthesia—Docetaxel—breast cancer	0.000125	0.000335	CcSEcCtD
Ceftriaxone—Erythema multiforme—Epirubicin—breast cancer	0.000125	0.000335	CcSEcCtD
Ceftriaxone—Vomiting—Gemcitabine—breast cancer	0.000125	0.000334	CcSEcCtD
Ceftriaxone—Rash—Gemcitabine—breast cancer	0.000124	0.000331	CcSEcCtD
Ceftriaxone—Dermatitis—Gemcitabine—breast cancer	0.000124	0.000331	CcSEcCtD
Ceftriaxone—Haemoglobin—Doxorubicin—breast cancer	0.000123	0.000329	CcSEcCtD
Ceftriaxone—Headache—Gemcitabine—breast cancer	0.000123	0.000329	CcSEcCtD
Ceftriaxone—Flushing—Epirubicin—breast cancer	0.000123	0.000329	CcSEcCtD
Ceftriaxone—Vomiting—Fluorouracil—breast cancer	0.000123	0.000329	CcSEcCtD
Ceftriaxone—Dyspepsia—Docetaxel—breast cancer	0.000123	0.000328	CcSEcCtD
Ceftriaxone—Haemorrhage—Doxorubicin—breast cancer	0.000123	0.000328	CcSEcCtD
Ceftriaxone—Rash—Fluorouracil—breast cancer	0.000122	0.000326	CcSEcCtD
Ceftriaxone—Dermatitis—Fluorouracil—breast cancer	0.000122	0.000326	CcSEcCtD
Ceftriaxone—Paraesthesia—Capecitabine—breast cancer	0.000121	0.000324	CcSEcCtD
Ceftriaxone—Hypersensitivity—Paclitaxel—breast cancer	0.000121	0.000324	CcSEcCtD
Ceftriaxone—Headache—Fluorouracil—breast cancer	0.000121	0.000324	CcSEcCtD
Ceftriaxone—Dysgeusia—Methotrexate—breast cancer	0.000121	0.000323	CcSEcCtD
Ceftriaxone—Cefoperazone—ALB—breast cancer	0.000121	0.119	CrCbGaD
Ceftriaxone—Nausea—Irinotecan—breast cancer	0.00012	0.00032	CcSEcCtD
Ceftriaxone—Nausea—Mitoxantrone—breast cancer	0.00012	0.00032	CcSEcCtD
Ceftriaxone—Pain—Docetaxel—breast cancer	0.000119	0.000319	CcSEcCtD
Ceftriaxone—Dyspepsia—Capecitabine—breast cancer	0.000119	0.000318	CcSEcCtD
Ceftriaxone—Chills—Epirubicin—breast cancer	0.000119	0.000318	CcSEcCtD
Ceftriaxone—Nausea—Gemcitabine—breast cancer	0.000117	0.000312	CcSEcCtD
Ceftriaxone—Pruritus—Paclitaxel—breast cancer	0.000117	0.000311	CcSEcCtD
Ceftriaxone—Erythema multiforme—Doxorubicin—breast cancer	0.000116	0.00031	CcSEcCtD
Ceftriaxone—Pain—Capecitabine—breast cancer	0.000116	0.000309	CcSEcCtD
Ceftriaxone—Feeling abnormal—Docetaxel—breast cancer	0.000115	0.000307	CcSEcCtD
Ceftriaxone—Nausea—Fluorouracil—breast cancer	0.000115	0.000307	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Methotrexate—breast cancer	0.000114	0.000306	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Docetaxel—breast cancer	0.000114	0.000305	CcSEcCtD
Ceftriaxone—Anaemia—Methotrexate—breast cancer	0.000114	0.000304	CcSEcCtD
Ceftriaxone—Flushing—Doxorubicin—breast cancer	0.000114	0.000304	CcSEcCtD
Ceftriaxone—Flatulence—Epirubicin—breast cancer	0.000114	0.000304	CcSEcCtD
Ceftriaxone—Dysgeusia—Epirubicin—breast cancer	0.000113	0.000302	CcSEcCtD
Ceftriaxone—Diarrhoea—Paclitaxel—breast cancer	0.000113	0.000301	CcSEcCtD
Ceftriaxone—Feeling abnormal—Capecitabine—breast cancer	0.000111	0.000298	CcSEcCtD
Ceftriaxone—Malaise—Methotrexate—breast cancer	0.000111	0.000297	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Capecitabine—breast cancer	0.000111	0.000295	CcSEcCtD
Ceftriaxone—Abdominal pain—Docetaxel—breast cancer	0.00011	0.000295	CcSEcCtD
Ceftriaxone—Body temperature increased—Docetaxel—breast cancer	0.00011	0.000295	CcSEcCtD
Ceftriaxone—Leukopenia—Methotrexate—breast cancer	0.00011	0.000295	CcSEcCtD
Ceftriaxone—Chills—Doxorubicin—breast cancer	0.00011	0.000294	CcSEcCtD
Ceftriaxone—Dizziness—Paclitaxel—breast cancer	0.000109	0.000291	CcSEcCtD
Ceftriaxone—Urticaria—Capecitabine—breast cancer	0.000107	0.000287	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Epirubicin—breast cancer	0.000107	0.000286	CcSEcCtD
Ceftriaxone—Abdominal pain—Capecitabine—breast cancer	0.000107	0.000285	CcSEcCtD
Ceftriaxone—Body temperature increased—Capecitabine—breast cancer	0.000107	0.000285	CcSEcCtD
Ceftriaxone—Convulsion—Methotrexate—breast cancer	0.000107	0.000285	CcSEcCtD
Ceftriaxone—Anaemia—Epirubicin—breast cancer	0.000107	0.000285	CcSEcCtD
Ceftriaxone—Agitation—Epirubicin—breast cancer	0.000106	0.000283	CcSEcCtD
Ceftriaxone—Flatulence—Doxorubicin—breast cancer	0.000105	0.000281	CcSEcCtD
Ceftriaxone—Vomiting—Paclitaxel—breast cancer	0.000105	0.00028	CcSEcCtD
Ceftriaxone—Dysgeusia—Doxorubicin—breast cancer	0.000105	0.000279	CcSEcCtD
Ceftriaxone—Malaise—Epirubicin—breast cancer	0.000104	0.000278	CcSEcCtD
Ceftriaxone—Rash—Paclitaxel—breast cancer	0.000104	0.000277	CcSEcCtD
Ceftriaxone—Dermatitis—Paclitaxel—breast cancer	0.000104	0.000277	CcSEcCtD
Ceftriaxone—Discomfort—Methotrexate—breast cancer	0.000104	0.000277	CcSEcCtD
Ceftriaxone—Leukopenia—Epirubicin—breast cancer	0.000103	0.000276	CcSEcCtD
Ceftriaxone—Headache—Paclitaxel—breast cancer	0.000103	0.000276	CcSEcCtD
Ceftriaxone—Hypersensitivity—Docetaxel—breast cancer	0.000103	0.000275	CcSEcCtD
Ceftriaxone—Palpitations—Epirubicin—breast cancer	0.000102	0.000272	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Methotrexate—breast cancer	0.000101	0.000269	CcSEcCtD
Ceftriaxone—Convulsion—Epirubicin—breast cancer	0.0001	0.000267	CcSEcCtD
Ceftriaxone—Infection—Methotrexate—breast cancer	0.0001	0.000267	CcSEcCtD
Ceftriaxone—Hypersensitivity—Capecitabine—breast cancer	9.96e-05	0.000266	CcSEcCtD
Ceftriaxone—Cefazolin—ALB—breast cancer	9.92e-05	0.098	CrCbGaD
Ceftriaxone—Ill-defined disorder—Doxorubicin—breast cancer	9.91e-05	0.000265	CcSEcCtD
Ceftriaxone—Pruritus—Docetaxel—breast cancer	9.88e-05	0.000264	CcSEcCtD
Ceftriaxone—Anaemia—Doxorubicin—breast cancer	9.87e-05	0.000264	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Methotrexate—breast cancer	9.86e-05	0.000263	CcSEcCtD
Ceftriaxone—Agitation—Doxorubicin—breast cancer	9.82e-05	0.000262	CcSEcCtD
Ceftriaxone—Nausea—Paclitaxel—breast cancer	9.79e-05	0.000261	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Methotrexate—breast cancer	9.73e-05	0.00026	CcSEcCtD
Ceftriaxone—Discomfort—Epirubicin—breast cancer	9.71e-05	0.000259	CcSEcCtD
Ceftriaxone—Malaise—Doxorubicin—breast cancer	9.63e-05	0.000257	CcSEcCtD
Ceftriaxone—Pruritus—Capecitabine—breast cancer	9.57e-05	0.000255	CcSEcCtD
Ceftriaxone—Leukopenia—Doxorubicin—breast cancer	9.56e-05	0.000255	CcSEcCtD
Ceftriaxone—Diarrhoea—Docetaxel—breast cancer	9.56e-05	0.000255	CcSEcCtD
Ceftriaxone—Palpitations—Doxorubicin—breast cancer	9.44e-05	0.000252	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Epirubicin—breast cancer	9.42e-05	0.000252	CcSEcCtD
Ceftriaxone—Oedema—Epirubicin—breast cancer	9.42e-05	0.000252	CcSEcCtD
Ceftriaxone—Infection—Epirubicin—breast cancer	9.36e-05	0.00025	CcSEcCtD
Ceftriaxone—Convulsion—Doxorubicin—breast cancer	9.25e-05	0.000247	CcSEcCtD
Ceftriaxone—Diarrhoea—Capecitabine—breast cancer	9.25e-05	0.000247	CcSEcCtD
Ceftriaxone—Dizziness—Docetaxel—breast cancer	9.24e-05	0.000247	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Epirubicin—breast cancer	9.22e-05	0.000246	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Epirubicin—breast cancer	9.11e-05	0.000243	CcSEcCtD
Ceftriaxone—Paraesthesia—Methotrexate—breast cancer	9.04e-05	0.000241	CcSEcCtD
Ceftriaxone—Discomfort—Doxorubicin—breast cancer	8.99e-05	0.00024	CcSEcCtD
Ceftriaxone—Dizziness—Capecitabine—breast cancer	8.94e-05	0.000239	CcSEcCtD
Ceftriaxone—Vomiting—Docetaxel—breast cancer	8.88e-05	0.000237	CcSEcCtD
Ceftriaxone—Dyspepsia—Methotrexate—breast cancer	8.86e-05	0.000237	CcSEcCtD
Ceftriaxone—Rash—Docetaxel—breast cancer	8.81e-05	0.000235	CcSEcCtD
Ceftriaxone—Dermatitis—Docetaxel—breast cancer	8.8e-05	0.000235	CcSEcCtD
Ceftriaxone—Headache—Docetaxel—breast cancer	8.75e-05	0.000234	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Doxorubicin—breast cancer	8.72e-05	0.000233	CcSEcCtD
Ceftriaxone—Oedema—Doxorubicin—breast cancer	8.72e-05	0.000233	CcSEcCtD
Ceftriaxone—Infection—Doxorubicin—breast cancer	8.66e-05	0.000231	CcSEcCtD
Ceftriaxone—Pain—Methotrexate—breast cancer	8.61e-05	0.00023	CcSEcCtD
Ceftriaxone—Vomiting—Capecitabine—breast cancer	8.6e-05	0.00023	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Doxorubicin—breast cancer	8.54e-05	0.000228	CcSEcCtD
Ceftriaxone—Rash—Capecitabine—breast cancer	8.53e-05	0.000228	CcSEcCtD
Ceftriaxone—Dermatitis—Capecitabine—breast cancer	8.52e-05	0.000227	CcSEcCtD
Ceftriaxone—Headache—Capecitabine—breast cancer	8.47e-05	0.000226	CcSEcCtD
Ceftriaxone—Paraesthesia—Epirubicin—breast cancer	8.46e-05	0.000226	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Doxorubicin—breast cancer	8.43e-05	0.000225	CcSEcCtD
Ceftriaxone—Nausea—Docetaxel—breast cancer	8.3e-05	0.000222	CcSEcCtD
Ceftriaxone—Feeling abnormal—Methotrexate—breast cancer	8.3e-05	0.000222	CcSEcCtD
Ceftriaxone—Dyspepsia—Epirubicin—breast cancer	8.29e-05	0.000221	CcSEcCtD
Ceftriaxone—Cefalotin—ALB—breast cancer	8.24e-05	0.0813	CrCbGaD
Ceftriaxone—Gastrointestinal pain—Methotrexate—breast cancer	8.23e-05	0.00022	CcSEcCtD
Ceftriaxone—Pain—Epirubicin—breast cancer	8.06e-05	0.000215	CcSEcCtD
Ceftriaxone—Nausea—Capecitabine—breast cancer	8.03e-05	0.000214	CcSEcCtD
Ceftriaxone—Urticaria—Methotrexate—breast cancer	8e-05	0.000214	CcSEcCtD
Ceftriaxone—Body temperature increased—Methotrexate—breast cancer	7.96e-05	0.000213	CcSEcCtD
Ceftriaxone—Abdominal pain—Methotrexate—breast cancer	7.96e-05	0.000213	CcSEcCtD
Ceftriaxone—Paraesthesia—Doxorubicin—breast cancer	7.83e-05	0.000209	CcSEcCtD
Ceftriaxone—Feeling abnormal—Epirubicin—breast cancer	7.76e-05	0.000207	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Epirubicin—breast cancer	7.7e-05	0.000206	CcSEcCtD
Ceftriaxone—Dyspepsia—Doxorubicin—breast cancer	7.67e-05	0.000205	CcSEcCtD
Ceftriaxone—Urticaria—Epirubicin—breast cancer	7.48e-05	0.0002	CcSEcCtD
Ceftriaxone—Pain—Doxorubicin—breast cancer	7.45e-05	0.000199	CcSEcCtD
Ceftriaxone—Body temperature increased—Epirubicin—breast cancer	7.45e-05	0.000199	CcSEcCtD
Ceftriaxone—Abdominal pain—Epirubicin—breast cancer	7.45e-05	0.000199	CcSEcCtD
Ceftriaxone—Hypersensitivity—Methotrexate—breast cancer	7.42e-05	0.000198	CcSEcCtD
Ceftriaxone—Feeling abnormal—Doxorubicin—breast cancer	7.18e-05	0.000192	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Doxorubicin—breast cancer	7.13e-05	0.00019	CcSEcCtD
Ceftriaxone—Pruritus—Methotrexate—breast cancer	7.12e-05	0.00019	CcSEcCtD
Ceftriaxone—Hypersensitivity—Epirubicin—breast cancer	6.94e-05	0.000185	CcSEcCtD
Ceftriaxone—Urticaria—Doxorubicin—breast cancer	6.93e-05	0.000185	CcSEcCtD
Ceftriaxone—Abdominal pain—Doxorubicin—breast cancer	6.89e-05	0.000184	CcSEcCtD
Ceftriaxone—Body temperature increased—Doxorubicin—breast cancer	6.89e-05	0.000184	CcSEcCtD
Ceftriaxone—Diarrhoea—Methotrexate—breast cancer	6.89e-05	0.000184	CcSEcCtD
Ceftriaxone—Pruritus—Epirubicin—breast cancer	6.67e-05	0.000178	CcSEcCtD
Ceftriaxone—Dizziness—Methotrexate—breast cancer	6.66e-05	0.000178	CcSEcCtD
Ceftriaxone—Diarrhoea—Epirubicin—breast cancer	6.45e-05	0.000172	CcSEcCtD
Ceftriaxone—Hypersensitivity—Doxorubicin—breast cancer	6.42e-05	0.000171	CcSEcCtD
Ceftriaxone—Vomiting—Methotrexate—breast cancer	6.4e-05	0.000171	CcSEcCtD
Ceftriaxone—Rash—Methotrexate—breast cancer	6.35e-05	0.000169	CcSEcCtD
Ceftriaxone—Dermatitis—Methotrexate—breast cancer	6.34e-05	0.000169	CcSEcCtD
Ceftriaxone—Headache—Methotrexate—breast cancer	6.31e-05	0.000168	CcSEcCtD
Ceftriaxone—Dizziness—Epirubicin—breast cancer	6.23e-05	0.000166	CcSEcCtD
Ceftriaxone—Pruritus—Doxorubicin—breast cancer	6.17e-05	0.000165	CcSEcCtD
Ceftriaxone—Vomiting—Epirubicin—breast cancer	5.99e-05	0.00016	CcSEcCtD
Ceftriaxone—Nausea—Methotrexate—breast cancer	5.98e-05	0.00016	CcSEcCtD
Ceftriaxone—Diarrhoea—Doxorubicin—breast cancer	5.96e-05	0.000159	CcSEcCtD
Ceftriaxone—Rash—Epirubicin—breast cancer	5.94e-05	0.000159	CcSEcCtD
Ceftriaxone—Dermatitis—Epirubicin—breast cancer	5.94e-05	0.000158	CcSEcCtD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—HMOX1—breast cancer	5.93e-05	0.000461	CbGpPWpGaD
Ceftriaxone—Headache—Epirubicin—breast cancer	5.9e-05	0.000158	CcSEcCtD
Ceftriaxone—ALB—Vitamin B12 Metabolism—TNF—breast cancer	5.88e-05	0.000457	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—IFNG—breast cancer	5.87e-05	0.000456	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—NCOA1—breast cancer	5.87e-05	0.000456	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—NCOA2—breast cancer	5.81e-05	0.000451	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—GPX1—breast cancer	5.81e-05	0.000451	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—RELA—breast cancer	5.79e-05	0.00045	CbGpPWpGaD
Ceftriaxone—Dizziness—Doxorubicin—breast cancer	5.76e-05	0.000154	CcSEcCtD
Ceftriaxone—GLUL—Metabolism—CYP1A1—breast cancer	5.75e-05	0.000446	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—FHL2—breast cancer	5.75e-05	0.000446	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—PLG—breast cancer	5.72e-05	0.000444	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—ERCC2—breast cancer	5.7e-05	0.000443	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—ABCB1—breast cancer	5.69e-05	0.000442	CbGpPWpGaD
Ceftriaxone—ALB—SLC-mediated transmembrane transport—SLC5A5—breast cancer	5.67e-05	0.00044	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—PTGS2—breast cancer	5.63e-05	0.000437	CbGpPWpGaD
Ceftriaxone—Nausea—Epirubicin—breast cancer	5.6e-05	0.000149	CcSEcCtD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PLG—breast cancer	5.56e-05	0.000432	CbGpPWpGaD
Ceftriaxone—Vomiting—Doxorubicin—breast cancer	5.54e-05	0.000148	CcSEcCtD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—SLC5A5—breast cancer	5.54e-05	0.000431	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—F3—breast cancer	5.52e-05	0.000428	CbGpPWpGaD
Ceftriaxone—Rash—Doxorubicin—breast cancer	5.5e-05	0.000147	CcSEcCtD
Ceftriaxone—Dermatitis—Doxorubicin—breast cancer	5.49e-05	0.000147	CcSEcCtD
Ceftriaxone—ALB—SLC-mediated transmembrane transport—SLC2A1—breast cancer	5.48e-05	0.000425	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—ATP7B—breast cancer	5.46e-05	0.000424	CbGpPWpGaD
Ceftriaxone—Headache—Doxorubicin—breast cancer	5.46e-05	0.000146	CcSEcCtD
Ceftriaxone—GLUL—Metabolism—MTHFR—breast cancer	5.36e-05	0.000416	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—SLC2A1—breast cancer	5.35e-05	0.000416	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—ABCC1—breast cancer	5.34e-05	0.000415	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PDGFA—breast cancer	5.28e-05	0.00041	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—HMOX1—breast cancer	5.28e-05	0.00041	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—IL1B—breast cancer	5.24e-05	0.000407	CbGpPWpGaD
Ceftriaxone—SLC22A6—SLC-mediated transmembrane transport—ALB—breast cancer	5.2e-05	0.000404	CbGpPWpGaD
Ceftriaxone—Nausea—Doxorubicin—breast cancer	5.18e-05	0.000138	CcSEcCtD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PPARGC1B—breast cancer	5.17e-05	0.000402	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—ITPR1—breast cancer	5.12e-05	0.000398	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—ABCC1—breast cancer	5.08e-05	0.000394	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—ABCB1—breast cancer	5.06e-05	0.000393	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—CAV1—breast cancer	4.94e-05	0.000384	CbGpPWpGaD
Ceftriaxone—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—breast cancer	4.93e-05	0.000383	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—NCOA1—breast cancer	4.9e-05	0.00038	CbGpPWpGaD
Ceftriaxone—ALB—Platelet degranulation—VEGFA—breast cancer	4.79e-05	0.000372	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—TNF—breast cancer	4.78e-05	0.000372	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—HGF—breast cancer	4.78e-05	0.000371	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PLA2G4A—breast cancer	4.78e-05	0.000371	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—PLG—breast cancer	4.77e-05	0.000371	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—GPX2—breast cancer	4.76e-05	0.00037	CbGpPWpGaD
Ceftriaxone—ALB—Vitamin B12 Metabolism—IL6—breast cancer	4.74e-05	0.000368	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—CSF2—breast cancer	4.73e-05	0.000367	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—GPX4—breast cancer	4.7e-05	0.000365	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—CFL1—breast cancer	4.6e-05	0.000358	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—IDH1—breast cancer	4.59e-05	0.000357	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—GRB7—breast cancer	4.56e-05	0.000354	CbGpPWpGaD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—breast cancer	4.56e-05	0.000354	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PIK3CG—breast cancer	4.5e-05	0.00035	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SYNJ2—breast cancer	4.45e-05	0.000346	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—HMOX1—breast cancer	4.4e-05	0.000342	CbGpPWpGaD
Ceftriaxone—ALB—Platelet degranulation—TGFB1—breast cancer	4.39e-05	0.000341	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—TUBB3—breast cancer	4.32e-05	0.000335	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—VEGFC—breast cancer	4.31e-05	0.000334	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—ALDOA—breast cancer	4.31e-05	0.000334	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—ABCB1—breast cancer	4.23e-05	0.000328	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—TP53—breast cancer	4.22e-05	0.000328	CbGpPWpGaD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—breast cancer	4.18e-05	0.000325	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—ALB—breast cancer	4.15e-05	0.000323	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—NDUFS3—breast cancer	4.14e-05	0.000322	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—MED12—breast cancer	3.98e-05	0.000309	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PIK3CD—breast cancer	3.96e-05	0.000307	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—ALB—breast cancer	3.91e-05	0.000303	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CHST9—breast cancer	3.89e-05	0.000302	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—IL6—breast cancer	3.86e-05	0.0003	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—ALB—breast cancer	3.84e-05	0.000298	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	3.81e-05	0.000296	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—TNF—breast cancer	3.8e-05	0.000295	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—RAF1—breast cancer	3.76e-05	0.000292	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—NOS3—breast cancer	3.74e-05	0.00029	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—FN1—breast cancer	3.71e-05	0.000288	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	3.7e-05	0.000288	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—COX11—breast cancer	3.69e-05	0.000287	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	3.63e-05	0.000282	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—TGFB2—breast cancer	3.62e-05	0.000282	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—THBS1—breast cancer	3.61e-05	0.00028	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC2A2—breast cancer	3.59e-05	0.000279	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—ALB—breast cancer	3.56e-05	0.000277	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—GATA3—breast cancer	3.55e-05	0.000276	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PIK3CG—breast cancer	3.55e-05	0.000276	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—ACHE—breast cancer	3.52e-05	0.000273	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—ABCG2—breast cancer	3.52e-05	0.000273	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—EGF—breast cancer	3.51e-05	0.000272	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—RAF1—breast cancer	3.47e-05	0.00027	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PIK3CB—breast cancer	3.45e-05	0.000268	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PTGS2—breast cancer	3.42e-05	0.000265	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CDA—breast cancer	3.38e-05	0.000262	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SHMT1—breast cancer	3.38e-05	0.000262	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	3.33e-05	0.000259	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	3.3e-05	0.000256	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SLC2A5—breast cancer	3.25e-05	0.000252	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SLCO1B1—breast cancer	3.25e-05	0.000252	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—IGF1—breast cancer	3.25e-05	0.000252	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—AKT2—breast cancer	3.25e-05	0.000252	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—RAF1—breast cancer	3.22e-05	0.00025	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—IFNB1—breast cancer	3.19e-05	0.000248	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	3.18e-05	0.000247	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—ALB—breast cancer	3.17e-05	0.000246	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—APRT—breast cancer	3.14e-05	0.000244	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—TFRC—breast cancer	3.14e-05	0.000244	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PIK3CD—breast cancer	3.12e-05	0.000242	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—SERPINE1—breast cancer	3.09e-05	0.00024	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—FASN—breast cancer	3.08e-05	0.000239	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—BCHE—breast cancer	3.07e-05	0.000238	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—IL6—breast cancer	3.07e-05	0.000238	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—NCOA2—breast cancer	3.02e-05	0.000235	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PTEN—breast cancer	2.98e-05	0.000232	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ESRRA—breast cancer	2.95e-05	0.000229	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ANGPTL4—breast cancer	2.95e-05	0.000229	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PLAUR—breast cancer	2.93e-05	0.000228	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC5A5—breast cancer	2.88e-05	0.000224	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PLG—breast cancer	2.87e-05	0.000223	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—RAF1—breast cancer	2.86e-05	0.000223	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	2.81e-05	0.000218	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GPI—breast cancer	2.8e-05	0.000217	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HADHB—breast cancer	2.8e-05	0.000217	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—RAF1—breast cancer	2.79e-05	0.000216	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC2A1—breast cancer	2.78e-05	0.000216	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PDGFA—breast cancer	2.72e-05	0.000211	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PIK3CB—breast cancer	2.72e-05	0.000211	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	2.68e-05	0.000208	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ALDH1A1—breast cancer	2.67e-05	0.000207	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ALDH7A1—breast cancer	2.67e-05	0.000207	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—ALB—breast cancer	2.64e-05	0.000205	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—ITPR1—breast cancer	2.64e-05	0.000205	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	2.64e-05	0.000205	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—ABL1—breast cancer	2.62e-05	0.000204	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—UMPS—breast cancer	2.56e-05	0.000199	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PHGDH—breast cancer	2.56e-05	0.000199	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ADSL—breast cancer	2.56e-05	0.000199	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—NME1—breast cancer	2.56e-05	0.000199	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—FHL2—breast cancer	2.56e-05	0.000199	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—NCOA1—breast cancer	2.54e-05	0.000198	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HPSE—breast cancer	2.51e-05	0.000195	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—BRIP1—breast cancer	2.51e-05	0.000195	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—LDHB—breast cancer	2.51e-05	0.000195	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—IL2—breast cancer	2.5e-05	0.000194	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—PLG—breast cancer	2.48e-05	0.000193	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PLA2G4A—breast cancer	2.46e-05	0.000191	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—HGF—breast cancer	2.46e-05	0.000191	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—CSF2—breast cancer	2.44e-05	0.000189	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—RAF1—breast cancer	2.39e-05	0.000186	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GSTA3—breast cancer	2.38e-05	0.000185	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HMMR—breast cancer	2.38e-05	0.000185	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ABCC1—breast cancer	2.38e-05	0.000185	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PPARGC1B—breast cancer	2.3e-05	0.000179	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—HMOX1—breast cancer	2.29e-05	0.000178	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	2.24e-05	0.000174	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	2.24e-05	0.000174	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—ABCB1—breast cancer	2.2e-05	0.000171	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—SRC—breast cancer	2.18e-05	0.000169	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CA9—breast cancer	2.18e-05	0.000169	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GSTA4—breast cancer	2.18e-05	0.000169	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—GPX1—breast cancer	2.15e-05	0.000167	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	2.13e-05	0.000165	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—VEGFA—breast cancer	2.12e-05	0.000165	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GSTA2—breast cancer	2.12e-05	0.000165	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GPX2—breast cancer	2.12e-05	0.000165	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PIK3CA—breast cancer	2.1e-05	0.000163	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—MMP1—breast cancer	2.09e-05	0.000163	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GPX4—breast cancer	2.09e-05	0.000163	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SULT1A1—breast cancer	2.09e-05	0.000163	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—CDK2—breast cancer	2.06e-05	0.00016	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PLAU—breast cancer	2.06e-05	0.00016	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GSTA1—breast cancer	2.05e-05	0.000159	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—IDH1—breast cancer	2.05e-05	0.000159	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—NAT2—breast cancer	2.02e-05	0.000157	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—CAV1—breast cancer	2.01e-05	0.000156	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—MAPK3—breast cancer	2.01e-05	0.000156	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—TGFB1—breast cancer	1.95e-05	0.000151	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—FN1—breast cancer	1.91e-05	0.000148	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—NOS2—breast cancer	1.89e-05	0.000147	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PIK3CG—breast cancer	1.83e-05	0.000142	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CAV1—breast cancer	1.83e-05	0.000142	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—EGF—breast cancer	1.81e-05	0.00014	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—DPYD—breast cancer	1.77e-05	0.000138	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—MED12—breast cancer	1.77e-05	0.000138	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ALDOA—breast cancer	1.75e-05	0.000136	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—AKT1—breast cancer	1.72e-05	0.000133	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—NCOA3—breast cancer	1.69e-05	0.000132	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SLC2A2—breast cancer	1.68e-05	0.000131	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—IGF1—breast cancer	1.68e-05	0.00013	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—AKT2—breast cancer	1.67e-05	0.00013	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.67e-05	0.000129	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PIK3CA—breast cancer	1.66e-05	0.000129	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CPT1A—breast cancer	1.65e-05	0.000128	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—MTR—breast cancer	1.65e-05	0.000128	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ABCG2—breast cancer	1.65e-05	0.000128	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HPGDS—breast cancer	1.62e-05	0.000126	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PIK3CD—breast cancer	1.61e-05	0.000125	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HBA1—breast cancer	1.61e-05	0.000125	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—SERPINE1—breast cancer	1.59e-05	0.000124	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ACHE—breast cancer	1.57e-05	0.000122	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GSTT1—breast cancer	1.57e-05	0.000122	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—NOS3—breast cancer	1.52e-05	0.000118	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CYP17A1—breast cancer	1.48e-05	0.000115	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ENO1—breast cancer	1.47e-05	0.000114	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PTGS1—breast cancer	1.47e-05	0.000114	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.46e-05	0.000114	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CYP2D6—breast cancer	1.44e-05	0.000112	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—RAF1—breast cancer	1.44e-05	0.000112	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—NCOA2—breast cancer	1.41e-05	0.00011	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PIK3CB—breast cancer	1.4e-05	0.000109	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—FASN—breast cancer	1.37e-05	0.000107	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—BCHE—breast cancer	1.37e-05	0.000106	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—AKT1—breast cancer	1.35e-05	0.000105	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SLC5A5—breast cancer	1.35e-05	0.000105	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SLC2A1—breast cancer	1.3e-05	0.000101	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—NQO1—breast cancer	1.3e-05	0.000101	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—IL2—breast cancer	1.29e-05	0.0001	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.28e-05	9.91e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CYP3A4—breast cancer	1.27e-05	9.87e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.26e-05	9.82e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CYP1B1—breast cancer	1.25e-05	9.7e-05	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—RAF1—breast cancer	1.24e-05	9.65e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HSP90AA1—breast cancer	1.23e-05	9.52e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—NCOA1—breast cancer	1.19e-05	9.26e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CYP19A1—breast cancer	1.17e-05	9.12e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—STK11—breast cancer	1.17e-05	9.12e-05	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—SRC—breast cancer	1.12e-05	8.72e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.1e-05	8.56e-05	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—VEGFA—breast cancer	1.09e-05	8.5e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—COMT—breast cancer	1.09e-05	8.48e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GSTP1—breast cancer	1.09e-05	8.44e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HMOX1—breast cancer	1.07e-05	8.33e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ITPR1—breast cancer	1.07e-05	8.31e-05	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—MAPK3—breast cancer	1.03e-05	8.04e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ABCB1—breast cancer	1.03e-05	7.99e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—TYMS—breast cancer	1.01e-05	7.85e-05	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—TGFB1—breast cancer	1e-05	7.8e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—NCOR1—breast cancer	9.99e-06	7.76e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PLA2G4A—breast cancer	9.99e-06	7.76e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GSTM1—breast cancer	9.99e-06	7.76e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GPX1—breast cancer	9.57e-06	7.43e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CYP1A1—breast cancer	9.47e-06	7.35e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ERCC2—breast cancer	9.39e-06	7.29e-05	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—KRAS—breast cancer	9.3e-06	7.22e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—MTHFR—breast cancer	8.83e-06	6.86e-05	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PIK3CA—breast cancer	8.55e-06	6.64e-05	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—TP53—breast cancer	8.27e-06	6.42e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CAV1—breast cancer	8.14e-06	6.32e-05	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—HRAS—breast cancer	7.91e-06	6.14e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	7.78e-06	6.04e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PIK3CG—breast cancer	7.42e-06	5.76e-05	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—AKT1—breast cancer	6.98e-06	5.42e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PIK3CD—breast cancer	6.52e-06	5.06e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—NOS3—breast cancer	6.16e-06	4.78e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PIK3CB—breast cancer	5.68e-06	4.41e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PTGS2—breast cancer	5.63e-06	4.37e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PTEN—breast cancer	4.91e-06	3.81e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PIK3CA—breast cancer	3.46e-06	2.69e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—AKT1—breast cancer	2.83e-06	2.2e-05	CbGpPWpGaD
